Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia

Background: Acute lymphoblastic leukemia (ALL) is a fetal hematologic disorder that is mostly observed in children. Both B and T lymphocytes have been reported to play a role in ALL etiology. Long non-coding RNAs (lncRNAs) are large regulatory molecules with more than 200nucleotides that participate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zohreh Mousavi, Saeid Ghorbian, Azim Rezamand, Leyla Roshangar, Behboud Jafari
Formato: article
Lenguaje:EN
Publicado: Tabriz University of Medical Sciences 2021
Materias:
Acceso en línea:https://doaj.org/article/da143d311d3b4653ab164991d67c4862
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da143d311d3b4653ab164991d67c4862
record_format dspace
spelling oai:doaj.org-article:da143d311d3b4653ab164991d67c48622021-11-29T05:53:31ZEvaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia2383-288610.34172/PS.2021.18https://doaj.org/article/da143d311d3b4653ab164991d67c48622021-12-01T00:00:00Zhttps://ps.tbzmed.ac.ir/PDF/ps-27-552.pdfhttps://doaj.org/toc/2383-2886Background: Acute lymphoblastic leukemia (ALL) is a fetal hematologic disorder that is mostly observed in children. Both B and T lymphocytes have been reported to play a role in ALL etiology. Long non-coding RNAs (lncRNAs) are large regulatory molecules with more than 200nucleotides that participate in various cellular processes. Methylation at the promoter regions of these regulatory molecules has been reported to vary between ALL patients and healthy controls. This study aimed to evaluate methylation status at promoter regions of lncRNAs between these two groups. Methods: In the current study, 80 ALL patients and 80 healthy controls were enrolled. The intravenous blood samples were obtained from all patients and controls. The extracted DNA from blood samples underwent sodium bisulfite treatment. Thereafter, methylation levels in the promoter regions of lncRNAs RP11-137H2.4, RP11-624c23.1, RP11-203E8, RP11-446E9, andRP11-68118.10 were evaluated using methylation specific‑high resolution melting (MS‑HRM). Moreover, the receiver operating characteristic curve (ROC) analysis was performed to examine the sensitivity and specificity of the tests. Results: The methylation levels of all studied lncRNAs including RP11-137H2.4, RP11-624c23.1, RP11-203E8, RP11-446E9, and RP11-68118.10 were significantly increased (p<0.05). ROC curve analysis also showed that all lncRNAs could be used as diagnostic markers. Conclusion: This study showed that methylation alterations of lncRNAs could be considered as novel biomarkers for early detection of ALL. Furthermore, owing to the possible role of studied lncRNAs as tumor suppressors, they could be reliable treatment targets for methylation modifications. Further research is still required to elucidate the role of these lncRNAs in ALL etiology.Zohreh MousaviSaeid GhorbianAzim RezamandLeyla RoshangarBehboud JafariTabriz University of Medical Sciencesarticlelong non-coding rnaacute lymphoblastic leukemiaoncogenesismethylationPharmacy and materia medicaRS1-441ENPharmaceutical Sciences, Vol 27, Iss 4, Pp 552-559 (2021)
institution DOAJ
collection DOAJ
language EN
topic long non-coding rna
acute lymphoblastic leukemia
oncogenesis
methylation
Pharmacy and materia medica
RS1-441
spellingShingle long non-coding rna
acute lymphoblastic leukemia
oncogenesis
methylation
Pharmacy and materia medica
RS1-441
Zohreh Mousavi
Saeid Ghorbian
Azim Rezamand
Leyla Roshangar
Behboud Jafari
Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
description Background: Acute lymphoblastic leukemia (ALL) is a fetal hematologic disorder that is mostly observed in children. Both B and T lymphocytes have been reported to play a role in ALL etiology. Long non-coding RNAs (lncRNAs) are large regulatory molecules with more than 200nucleotides that participate in various cellular processes. Methylation at the promoter regions of these regulatory molecules has been reported to vary between ALL patients and healthy controls. This study aimed to evaluate methylation status at promoter regions of lncRNAs between these two groups. Methods: In the current study, 80 ALL patients and 80 healthy controls were enrolled. The intravenous blood samples were obtained from all patients and controls. The extracted DNA from blood samples underwent sodium bisulfite treatment. Thereafter, methylation levels in the promoter regions of lncRNAs RP11-137H2.4, RP11-624c23.1, RP11-203E8, RP11-446E9, andRP11-68118.10 were evaluated using methylation specific‑high resolution melting (MS‑HRM). Moreover, the receiver operating characteristic curve (ROC) analysis was performed to examine the sensitivity and specificity of the tests. Results: The methylation levels of all studied lncRNAs including RP11-137H2.4, RP11-624c23.1, RP11-203E8, RP11-446E9, and RP11-68118.10 were significantly increased (p<0.05). ROC curve analysis also showed that all lncRNAs could be used as diagnostic markers. Conclusion: This study showed that methylation alterations of lncRNAs could be considered as novel biomarkers for early detection of ALL. Furthermore, owing to the possible role of studied lncRNAs as tumor suppressors, they could be reliable treatment targets for methylation modifications. Further research is still required to elucidate the role of these lncRNAs in ALL etiology.
format article
author Zohreh Mousavi
Saeid Ghorbian
Azim Rezamand
Leyla Roshangar
Behboud Jafari
author_facet Zohreh Mousavi
Saeid Ghorbian
Azim Rezamand
Leyla Roshangar
Behboud Jafari
author_sort Zohreh Mousavi
title Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
title_short Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
title_full Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
title_fullStr Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
title_full_unstemmed Evaluation of Methylation at Promoter Regions of Long Non-coding RNAs in Patients with Acute Lymphoblastic Leukemia
title_sort evaluation of methylation at promoter regions of long non-coding rnas in patients with acute lymphoblastic leukemia
publisher Tabriz University of Medical Sciences
publishDate 2021
url https://doaj.org/article/da143d311d3b4653ab164991d67c4862
work_keys_str_mv AT zohrehmousavi evaluationofmethylationatpromoterregionsoflongnoncodingrnasinpatientswithacutelymphoblasticleukemia
AT saeidghorbian evaluationofmethylationatpromoterregionsoflongnoncodingrnasinpatientswithacutelymphoblasticleukemia
AT azimrezamand evaluationofmethylationatpromoterregionsoflongnoncodingrnasinpatientswithacutelymphoblasticleukemia
AT leylaroshangar evaluationofmethylationatpromoterregionsoflongnoncodingrnasinpatientswithacutelymphoblasticleukemia
AT behboudjafari evaluationofmethylationatpromoterregionsoflongnoncodingrnasinpatientswithacutelymphoblasticleukemia
_version_ 1718407615342444544